During the past decade, Montreal Chest Institute McGill University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montreal Chest Institute McGill University" #1 sponsor was "Centers for Disease Control and Prevention" with 10 trials, followed by "Boston Scientific Corporation" with 1 trials sponsored, "Laval University" with 1 trials sponsored, "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 1 trials sponsored and "Ottawa Hospital Research Institute" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montreal Chest Institute McGill University" #1 collaborator was "US Department of Veterans Affairs" with 8 trials as a collaborator, "Université de Montréal" with 2 trials as a collaborator, "Argos Therapeutics" with 1 trials as a collaborator, "CIHR Canadian HIV Trials Network" with 1 trials as a collaborator and "Ontario HIV Treatment Network" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Montreal Chest Institute McGill University" are "Tuberculosis" (8 trials), "HIV Infections" (4 trials), "Pulmonary Tuberculosis" (2 trials), "Acquired Immunodeficiency Syndrome" (1 trials) and "Asthma" (1 trials). Many other conditions were trialed in "Montreal Chest Institute McGill University" in a lesser frequency.

Most popular intervention types in "Montreal Chest Institute McGill University" are "Drug" (11 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rifabutin" (4 trials), "Isoniazid" (3 trials), "Rifapentine" (2 trials), "rifapentine" (2 trials) and "25-desacetyl Rifapentine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montreal Chest Institute McGill University" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Montreal Chest Institute McGill University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Montreal Chest Institute McGill University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Montreal Chest Institute McGill University, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".